Skip to main content

Court Grants Temporary Stay On JUUL's Vape Products Ban

Court Grants Temporary Stay On JUUL's Vape Products Ban

Court Grants Temporary Stay On JUUL's Vape Products Ban

Introduction

Food and Drug Administration's (FDA) order to ban the sale of JUUL's e-cigarettes has been temporarily blocked by a federal court as the manufacturer has asked for additional time to file an appeal of the recent regulatory decision.

Earlier, FDA rejected the authorization of JUUL vaping products and asked the manufacturer to discontinue the sale and recall the products from the U.S. market, citing the long-term effects of teen vaping addiction.

JUUL introduced vape pens in a variety of flavors in 2015 with a design similar to a USB drive. This allowed the teens to hide their products and vaping habits from parents and school officials. Eventually, the e-cigarettes became popular among the teens, which increased the addiction problems throughout the nation.

The manufacturer's deceptive marketing through social media, and other mediums to lure the teens, additionally fueled the addiction crisis. These misleading strategies even led non-smokers to use vape pens. FDA issued a ban on the products to control the skyrocketing teen nicotine addiction rate.

JUUL denied the FDA's order and appealed the decision in the court. JUUL Lab’s Chief Regulatory Officer defended their products by stating that the products are compliant with the statutory standards that make the products appropriate for the protection of public health.

JUUL is even considering filing for Chapter 11 bankruptcy to deal with the ban as a majority of the revenue from the sale of the products for the manufacturer comes from the U.S.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.